title: Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated?
authors.affiliation: Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. oussama.abla@sickkids.ca
authors.forename: Oussama
authors.initials: O
authors.lastname: Abla
authors.forename: Sheila
authors.initials: S
authors.lastname: Weitzman
authors.forename: Milen
authors.initials: M
authors.lastname: Minkov
authors.forename: Kenneth L
authors.initials: KL
authors.lastname: McClain
authors.forename: Johannes
authors.initials: J
authors.lastname: Visser
authors.forename: Alexandra
authors.initials: A
authors.lastname: Filipovich
authors.forename: Nicole
authors.initials: N
authors.lastname: Grois
mesh_terms: D003919:Diabetes Insipidus / Q000150:complications* / Q000628:therapy*; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000628:therapy*; D006801:Humans